Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination. [PDF]
Ment Health ClinIntroduction: Opioid overdose deaths continue to rise despite available safe and efficacious treatments for opioid use disorder, such as buprenorphine. Whereas provider-level access to buprenorphine has improved, community pharmacy-level barriers remain,
Roth W, Dadiomov D.
europepmc +2 more sources
Interacti on of buprenorphine with phosphatidylcholine [PDF]
Thermochimica Acta, 1989 The interaction between phosphatidylcholine and buprenorphine have been studied by means of differential scanning calorimetry of liposome, compression isotherms and penetration kinetics of monolayers. The results show that the interactions are highly dependent on the ionized state of the buprenorphine molecules, being higher in buffered solutions.
F. Reig +5 more
openalex +4 more sources
Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men [PDF]
Addiction and Health, 2018 Background: Buprenorphine sublingual tablets are now available in Iran for opioid detoxification in clinics. Aim of the present study was to compare the efficiency of buprenorphine with buprenorphine/naloxone in short-term detoxification in a group of ...
Hassan Ziaaddini +4 more
doaj +4 more sources
Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl. [PDF]
Addict Sci Clin PractBackground In response to greater illicit fentanyl use, buprenorphine daily doses exceeding the FDA’s recommended target daily dose (16 mg) and maximum suggested daily dose (24 mg) may provide better outcomes, but little is known about higher dosage ...
Stein BD +4 more
europepmc +2 more sources
Buprenorphine and temazepam—abuse [PDF]
British Journal of Addiction, 1990 Richard Hammersley +2 more
openalex +4 more sources
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine [PDF]
Drug and Alcohol Review, 2021 AbstractBuprenorphine is a partial opioid agonist commonly used to treat opioid dependence. The pharmacology of buprenorphine increases the risk of a precipitated opioid withdrawal when commencing patients on buprenorphine treatment, particularly when transferring from long acting opioids (e.g. methadone).
Bridget Oakley +3 more
openaire +3 more sources
Acta Crystallographica Section E Structure Reports Online, 2014 In the crystal structure of a semi-synthetic opioid drug buprenorphine, C29H41NO4{systematic name: (2S)-2-[(5R,6R,7R,14S)-9α-cyclopropylmethyl-3-hydroxy-6-methoxy-4,5-epoxy-6,14-ethanomorphinan-7-yl]-3,3-dimethylbutan-2-ol}, the cyclopropylmethyl group is disordered over two sites with an occupancy factor of 0.611 (3) for the major component.
Jaroslaw Mazurek +4 more
openaire +3 more sources
Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study
Harm Reduction Journal, 2023 Background Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD).
Joëlla W. Adams +5 more
doaj +1 more source
Patterns of Routes of Administration and Drug Tampering for Nonmedical Opioid Consumption: Data Mining and Content Analysis of Reddit Discussions [PDF]
J Med Internet Res 2021;23(1):e21212, 2021 The complex unfolding of the US opioid epidemic in the last 20 years has been the subject of a large body of medical and pharmacological research, and it has sparked a multidisciplinary discussion on how to implement interventions and policies to effectively control its impact on public health.
arxiv +1 more source